REG - Alliance Pharma PLC - Management Update

Alliance PharmaAnnouncement

08/05/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240508:nRSH5720Na&default-theme=true

RNS Number : 5720N  Alliance Pharma PLC  08 May 2024

 

 For immediate release  8 May 2024

 

 

 

ALLIANCE PHARMA

("Alliance", "Company" or the "Group")

 

Management update

 

Alliance Pharma plc (AIM: APH), the international healthcare group, announces
that Peter Butterfield, Chief Executive Officer ("CEO"), has decided to leave
the business in order to pursue other business interests. Following a
comprehensive search process, Nick Sedgwick has been appointed as the new CEO,
starting 13 May 2024. Peter will remain at Alliance until 30 June 2024 to
facilitate a thorough handover.

 

Peter joined the Board of Alliance in 2010 and became CEO in 2018, driving a
strategy to increase the focus on consumer healthcare and extending the
Company's global reach into APAC and the US.

 

Nick Sedgwick brings thirty years of consumer health experience across
European, US and global roles at major multinational companies such as
Reckitt, Coty and Nestlé. Most recently Nick was Regional Director for UK and
Ireland Consumer Health at Reckitt during which time he increased revenue and
improved profitability in the second largest market for the company. Prior to
this, Nick worked at Coty holding a number of senior roles including Senior
Vice President for Global Sales and Commercial Capabilities, Senior Vice
President Sales for the US business and General Manager Consumer Beauty for UK
and Ireland. Throughout his career, Nick has worked in multiple countries,
always delivering high revenue growth through consumer-centric strategies,
high performance teams and excellence in execution.

 

Camillo Pane, Chair of Alliance, said:

"The Board and I would like to thank Peter for everything that he has done for
Alliance. He led Alliance's transition towards Consumer Healthcare and Group
revenues have almost doubled since he became CEO. We wish Peter well in his
future endeavours.

 

"We welcome Nick to Alliance and look forward to working with him as he leads
the Company through the next phase of its growth and development."

 

Peter Butterfield, Chief Executive Officer of Alliance, said:

"It has been a genuine privilege to lead Alliance over the last six years
through a period of growth and transformation. I am very confident that the
Company is in good hands and look forward to seeing it go from strength to
strength."

 

Nick Sedgwick, Chief Executive Officer designate of Alliance, said:

"I am really excited to be joining Alliance at such an important time for the
business. I look forward to getting to know the Company in depth over the next
few months and working with the management team to deliver the next phase of
growth."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Nicholas
John Sedgwick (aged 51 years) holds/has held the following
directorships/partnerships in the last five years:

 

 Current directorships/partnerships  Previous directorships/partnerships (last five years)
 None                                RB UK Commercial Limited

                                     Proprietary Association of Great Britain

                                     Cosmetic, Toiletry and Perfumery Association Limited

 

Mr Sedgwick currently holds no ordinary shares in the Company.

 

There are no further disclosures to made be under Schedule 2(g) of the AIM
Rules for Companies.

 

For further information:

 

 Alliance Pharma plc                                                       + 44 (0)1249 466966
 Cora McCallum, Head of Investor Relations & Corporate Communications      + 44 (0)1249 705168
 ir@allianceph.com (mailto:ir@allianceph.com)

 Buchanan                                                                  + 44 (0)20 7466 5000
 Mark Court / Sophie Wills
 alliancepharma@buchanan.uk.com (mailto:alliancepharma@buchanan.uk.com)

 Deutsche Numis (Nominated Adviser and Joint Broker)                       + 44 (0)20 7260 1000
 Freddie Barnfield / Duncan Monteith / Sher Shah

 Investec Bank plc (Joint Broker)                                          + 44 (0)20 7597 5970
 Patrick Robb / Lydia Zychowska

 

About Alliance

Alliance Pharma plc (AIM: APH) is a growing consumer healthcare company. Our
purpose is to empower people to make a positive difference to their health and
wellbeing by making our trusted and proven brands available around the world.

 

We deliver organic growth through investing in our priority brands and
channels, in related innovation, and through selective geographic expansion to
increase the reach of our brands. Periodically, we may look to enhance our
organic growth through selective, complementary acquisitions.

 

Headquartered in the UK, the Group employs around 285 people based in
locations across Europe, North America, and the Asia Pacific region. By
outsourcing our manufacturing and logistics we remain asset-light and focused
on maximising the value we can bring, both to our stakeholders and to our
brands.

 

For more information on Alliance, please visit our
website: www.alliancepharmaceuticals.com
(http://www.alliancepharmaceuticals.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDFZGGKKRNGDZG